Comirnaty concentrate for dispersion for injection

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

53. シェーグレン症候群

臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-001414-10-NL (EUCTR)	30/03/2021	24/03/2021	Response to corona vaccination in patients with primary Sjögren's syndrome	Vaccine response against SARS-CoV-2 in patients with primary Sjögren’s syndrome - VaccineSS	Primary Sjögren's syndrome;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Comirnaty concentrate for dispersion for injection Trade Name: COVID-19 Vaccine AstraZene ...	University Medical Center Groningen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 4	Netherlands

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-003277-55-AT (EUCTR)	01/09/2021	27/07/2021	COVID-19 Antibody Responses in Cystic Fibrosis: CAR-CF	COVID-19 Antibody Responses in Cystic Fibrosis: CAR-CF - CAR-CF	COVID-19 vaccine Antibody response from natural infection or after vaccination in patients with Cyst ...	Trade Name: Comirnaty concentrate for dispersion for injection Product Name: Comirnaty INN or Proposed ...	Medical University of Innsbruck, University Clinic for Pediatrics III	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	5000	Phase 4	United States;European Union;Canada;Ireland;Austria;United Kingdom